Please use this identifier to cite or link to this item: https://hdl.handle.net/10137/7495
Email LibraryRMU.DOH@nt.gov.au to ask for this document in a different format
Title: 3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial Activity.
Authors: Xue, Lian
Shi, Da-Hua
Harjani, Jitendra R
Huang, Fei
Beveridge, Julia G
Dingjan, Tamir
Ban, Kung
Diab, Sarah
Duffy, Sandra
Lucantoni, Leonardo
Fletcher, Sabine
Chiu, Francis C K
Blundell, Scott
Ellis, Katherine
Ralph, Stuart A
Wirjanata, Grennady
Teguh, Silvia
Noviyanti, Rintis
Chavchich, Marina
Creek, Darren
Price, Ric N
Marfurt, Jutta
Charman, Susan A
Cuellar, Matthew E
Strasser, Jessica M
Dahlin, Jayme L
Walters, Michael A
Edstein, Michael D
Avery, Vicky M
Baell, Jonathan B
Citation: Journal of medicinal chemistry 2019-03-14; 62(5): 2485-2498
Abstract: A series of 3,3'-disubstituted 5,5'-bi(1,2,4-triazine) derivatives was synthesized and screened against the erythrocytic stage of Plasmodium falciparum 3D7 line. The most potent dimer, 6k, with an IC50 (50% inhibitory concentration) of 0.008 μM, had high in vitro potency against P. falciparum lines resistant to chloroquine (W2, IC50 = 0.0047 ± 0.0011 μM) and artemisinin (MRA1240, IC50 = 0.0086 ± 0.0010 μM). Excellent ex vivo potency of 6k was shown against clinical field isolates of both P. falciparum (IC50 = 0.022-0.034 μM) and Plasmodium vivax (IC50 = 0.0093-0.031 μM) from the blood of outpatients with uncomplicated malaria. Despite 6k being cleared relatively rapidly in mice, it suppressed parasitemia in the Peters 4-day test, with a mean ED50 value (50% effective dose) of 1.47 mg kg-1 day-1 following oral administration. The disubstituted triazine dimer 6k represents a new class of orally available antimalarial compounds of considerable interest for further development.
Click to open PubMed article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/30715882
Click to open Pubmed Article: https://www.ezpdhcs.nt.gov.au/login?url=https://www.ncbi.nlm.nih.gov/pubmed/30715882
Journal title: Journal of medicinal chemistry
Publication Date: 2019-03-14
Type: Journal Article
URI: https://hdl.handle.net/10137/7495
DOI: 10.1021/acs.jmedchem.8b01799
metadata.dc.identifier.orcid: http://orcid.org/0000-0001-7497-7082
http://orcid.org/0000-0001-5650-9277
http://orcid.org/0000-0003-2114-8242
Appears in Collections:(a) NT Health Research Collection

Files in This Item:
There are no files associated with this item.


Items in ePublications are protected by copyright, with all rights reserved, unless otherwise indicated.